Clinical Research Directory
Browse clinical research sites, groups, and studies.
Markers of Osteoporosis in Cystic Fibrosis
Sponsor: University of Texas Southwestern Medical Center
Summary
Main Study Up to 100 subjects, both non-CF volunteers and Cystic Fibrosis (CF) patients, will participate in a single study visit that will include a DEXA scan, micro CT, and blood collection. Denosumab (Prolia) Sub study Approximately 10 adult subjects with CF who participated in the main study and have results indicating bone disease will receive treatment with Denosumab for up to 5 years. They will be asked to return for repeat DEXA scans, micro CT, blood collection, and documenting of any adverse events.
Key Details
Gender
All
Age Range
18 Years - 64 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2021-09-02
Completion Date
2027-07
Last Updated
2026-05-05
Healthy Volunteers
Yes
Conditions
Interventions
Denosumab
treatment with denosumab every 6 months for up to 5 years
Locations (1)
UT Southwestern Medical Center
Dallas, Texas, United States